[Strategies for antifungal treatment failure in intensive care units]

Anaesthesist. 2015 Sep;64(9):643-58. doi: 10.1007/s00101-015-0072-0.
[Article in German]

Abstract

Recent epidemiologic studies reveal both an increasing incidence and an escalation in resistance of invasive fungal infections in intensive care units. Primary therapy fails in 70 % of cases, depending on the underlying pathogens and diseases. The purpose of this review is to raise awareness for the topic of antifungal therapy failure, describe the clinical conditions in which it occurs, and suggest a possible algorithm for handling the situation of suspected primary therapy failure.

Keywords: Algorithm; Aspergillosis; Candidiasis; Fungemia; Sepsis.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy
  • Aspergillosis / microbiology
  • Candidiasis / drug therapy
  • Candidiasis / microbiology
  • Critical Care / methods*
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Drug Resistance, Fungal
  • Humans
  • Intensive Care Units
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Sepsis / drug therapy
  • Sepsis / microbiology
  • Treatment Failure

Substances

  • Antifungal Agents